|
|
Douglas Hanahan, Gabriele Bergers, Emily Bergsland
J Clin Invest. 2000;
105(8):1045
doi:10.1172/JCI9872
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine
Steven Chuan-Hao Kao, Rozelle Harvie, Florian Paturi, Robyn Taylor, Ross Davey, Rick Abraham, Stephen Clarke, Gavin Marx, Martin Cullen, Zoltan Kerestes |
Lung Cancer |
2011 |
.
|
Exploring and challenging the network of angiogenesis
Raúl Montañez, Francisca Sánchez-Jiménez, Ana R. Quesada, Miguel Ángel Medina |
Sci Rep |
2011 |
.
|
Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer – Review of the literature
T. Nelius, K. Rinard, S. Filleur |
Canc Treat Rev |
2011 |
.
|
Nanochannel Technology for Constant Delivery of Chemotherapeutics: Beyond Metronomic Administration
Alessandro Grattoni, Haifa Shen, Daniel Fine, Arturas Ziemys, Jaskaran S. Gill, Lee Hudson, Sharath Hosali, Randy Goodall, Xuewu Liu, Mauro Ferrari |
PHARMA RES |
2010 |
.
|
Metronomic chemotherapy: new rationale for new directions
Eddy Pasquier, Maria Kavallaris, Nicolas André |
Nat Rev Clin Oncol |
2010 |
.
|
Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy
Xiao-zhong Zhu, Hong-mei Yin, Jiong Mei |
Acta Pharmacol Sinica |
2010 |
.
|
Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas
Leandro E. Mainetti, Viviana R. Rozados, Ana Rossa, R. Daniel Bonfil, O. Graciela Scharovsky |
J Canc Res Clin Oncol |
2010 |
.
|
Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
Raffaele Addeo, Alessandro Sgambato, Gregorio Cennamo, Liliana Montella, Vincenzo Faiola, Alberto Abbruzzese, Elena Capasso, Luigi Leo, Gerardo Botti, Michele Caraglia, Salvatore Del Prete |
Clinical Breast Cancer |
2010 |
.
|
AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer
I V Subramanian, S Devineni, R Ghebre, G Ghosh, H P Joshi, Y Jing, A M Truskinovsky, S Ramakrishnan |
Gene Ther |
2010 |
.
|
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
Stefanie Meyer, Thomas Vogt, Michael Landthaler, Anna Berand, Albrecht Reichle, Frauke Bataille, Andreas H. Marx, Anne Menz, Arndt Hartmann, Leoni A. Kunz-Schughart, Peter J. Wild |
PPAR Research |
2010 |
.
|
La chimiothérapie métronomique du cancer du sein métastatique: à propos d’un cas
A. Gaumier, S. Hamizi, B. You, G. Freyer |
Oncologie |
2010 |
.
|
A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC
Athanasios G. Pallis, Vassilis Chandrinos, Georgia Pavlakou, Nikolaos Xenidis, Ioannis Varthalitis, Nikolaos Vardakis, Lambros Vamvakas, Emmanouel Kontopodis, Maria Rovithi, Vassilis Georgoulias |
Cancer Chemother Pharmacol |
2010 |
.
|
Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth
Shingo Takano, Hiroshi Kamiyama, Ryota Mashiko, Satoru Osuka, Eiichi Ishikawa, Akira Matsumura |
J Neurooncol |
2010 |
.
|
Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin
M. P. Rivera-Fillat, F. Reig, E. M. Martínez, M. R. Grau-Oliete |
J Pep Sci |
2010 |
.
|
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives
Ying-Chun Shen, Chiun Hsu, Ann-Lii Cheng |
J Gastroenterology |
2010 |
.
|
Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma
Fan Zhou, Lieping Guo, Haotian Shi, Chenhui Lin, Jian Hou |
Clinical Lymphoma, Myeloma & Leukemia |
2010 |
.
|
Optimizing the Delivery of Cancer Drugs That Block Angiogenesis
Y. Cao, R. Langer |
Science Translational Medicine |
2010 |
.
|
The tumour microenvironment: a novel target for cancer therapy
E Hanna, J Quick, SK Libutti |
Oral Dis |
2009 |
.
|
Safety of Bevacizumab in Advanced Ovarian and Müllerian Cancers: A Review
Susana M. Campos, Benjamin D. Humphreys |
Clinical Cancer Reviews |
2009 |
.
|
Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model
D. Fuentes, J. Avellanet, A. Garcia, N. Iglesias, M. R. Gabri, D. F. Alonso, A. M. Vazquez, R. Perez, E. Montero |
Breast Cancer Res Treat |
2009 |
.
|
|
|
|
